Point72 Asset Management’s Merck MRK Stock Holding History

Point72 Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.26M	Buy	68,700 +6,900	+11%	+$797K	0.01%	1374
2025 Q4	$6.51M	Buy	61,800 +14,400	+30%	+$1.35M	0.01%	1642
2025 Q3	$3.98M	Buy	47,400 +39,300	+485%	+$3.24M	0.01%	1158
2025 Q2	$641K	Sell	8,100 -93,900	-92%	-$7.46M	﹤0.01%	1711
2025 Q1	$9.16M	Buy	102,000 +100,000	+5,000%	+$9.34M	0.02%	713
2024 Q4	$199K	Sell	2,000 -100,000	-98%	-$10.3M	﹤0.01%	1888
2024 Q3	$11.6M	Buy	102,000 +100,000	+5,000%	+$11.9M	0.03%	597
2024 Q2	$248K	Hold	2,000	–	–	﹤0.01%	1578
2024 Q1	$264K	Hold	2,000	–	–	﹤0.01%	1825
2023 Q4	$218K	Sell	2,000 -37,500	-95%	-$3.89M	﹤0.01%	1783
2023 Q3	$4.07M	Buy	+39,500	New	+$4.26M	0.01%	944
2023 Q1	–	Sell	-55,000	Closed	-$6.1M	–	2429
2022 Q4	$6.1M	Buy	+55,000	New	+$5.62M	0.02%	703

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's MRK Position: Q1 2026 in Review

Point72 Asset Management reduced its Merck (MRK) stake by 31% in Q1 2026, selling an estimated $48.2M and leaving 921,077 shares worth $111M. The position accounts for 0.14% of the portfolio, ranked #151.

Point72 Asset Management first reported a position in MRK in Q2 2014 and has held it in 30 quarters since. The position peaked at $294M in Q1 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Point72 Asset Management held 921,077 shares of Merck worth $111M as of Q1 2026.
Point72 Asset Management sold 417,372 Merck shares in Q1 2026, an estimated $48.2M.
Merck made up 0.14% of Point72 Asset Management's portfolio in Q1 2026, its #151 holding.
Point72 Asset Management first reported a position in Merck in Q2 2014 and has held it in 30 quarters since.
Point72 Asset Management's Merck position peaked at $294M in Q1 2022.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.